SCHEMBL19464355

SCHEMBL19464355

COCCOc1cnc(C)c(-c2csc3ccc(COc4ccc(CCC(=O)O)cn4)cc23)c1

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 20/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19486368 0.89 FFAR1 (0.65) FFAR1
SCHEMBL19734275 0.85 FFAR1 (0.71) FFAR1
SCHEMBL17669380 0.84 FFAR1 (1.00) FFAR1
SCHEMBL19451048 0.84 FFAR1 (0.77) FFAR1
SCHEMBL19464344 0.84 FFAR1 (0.77) FFAR1
SCHEMBL17669265 0.84 FFAR1 (1.00) FFAR1
SCHEMBL22014084 0.83 FFAR1 (0.63) FFAR1
SCHEMBL19734295 0.82 FFAR1 (0.68) FFAR1
SCHEMBL19486339 0.80 FFAR1 (0.80) FFAR1
SCHEMBL17669473 0.80 FFAR1 (0.60) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790198-B2 Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes JANSSEN PHARMACEUTICA NV (BE) 2017-10-17 US disclosed